Final Efficacy Results Of Ncic Ctg Ind.202: A Randomized Phase Ii Study Of Recombinant Interleukin-21 (Ril21) In Patients With Recurrent Or Metastatic Melanoma (Mm)Teresa M. Petrella, Catalin Liviu Dragos Mihalcioiu,Elaine McWhirter,Karl Belanger,Kerry J. Savage,Xinni Song,Omid Hamid,Tina Cheng, Mary L. Davis, Christopher W. Lee,Alan Spatz,Jose Gerard Monzon,Linda Hagerman,Bingshu E. Chen,Janet DanceyJOURNAL OF CLINICAL ONCOLOGY（2013）引用 30|浏览17暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
